Screener
Haemonetics HAE Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 |
|---|---|---|
| Proceeds from exercise of stock options | 426 | 462 |
| Cash used to net share settle employee equity awards | (3,500) | (4,781) |
| Other financing activities | (14) | (36) |
| Net cash used in financing activities | (51,528) | (2,442) |
| Effect of exchange rates on cash and cash equivalents | (617) | 4,182 |
| Net Change in Cash and Cash Equivalents | (22,056) | (13,865) |
| Cash and Cash Equivalents at Beginning of Period | 245,440 | 306,763 |
| Cash and Cash Equivalents at End of Period | $223,384 | $292,898 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's net change in cash?
- Haemonetics (HAE) reported net change in cash of -$22.06M in Q2 2026.
- How has Haemonetics's net change in cash changed year-over-year?
- Haemonetics's net change in cash decreased by 59.1% year-over-year, from -$13.87M to -$22.06M.
- What is the long-term trend for Haemonetics's net change in cash?
- Over 3 years (2022 to 2026), Haemonetics's net change in cash has grown at a -1.2% compound annual growth rate (CAGR), from $67.19M to -$64.85M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Haemonetics's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude